Project Title

Clindamycin plus quinine for treating uncomplicated falciparum malaria: an open-label randomized trial

EDCTP Project Call

Senior Fellowship (SF)

Project Objectives

To measure the clinical and parasitological efficacy of Clindamycin plus quinine and Artemether-Lumefantrine (current recommended regimen) among patients between 6-59 months of age suffering from uncomplicated P. falciparum malaria, by determining the proportion of patients with Early Treatment Failures (ETF), Late Clinical Failures (LCF), Late Parasitological Failures (LPF), or with Adequate Clinical and Parasitological Response (ACPR) during a 28 day follow-up period.

Study Design

Phase IV open-label randomised trial

Host Organisation

Sites

Results & Outcomes

Current Organisation

Kenya Medical Research Institute

Current Job Title

Chief Research Officer

Biography